ATI-D1

N/A

Report date: 2025/02/07 12:00:18

Base Information

Drug NameATI-D1
Drug Alias NameATI-D1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProtein jagged-1 inhibitors
TargetsProtein jagged-1
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvantGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlanis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A